1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in Sweden
2024) In Infectious Diseases(
- Contribution to journal › Article
- 2023
-
Mark
European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination : 2023 revision
(
- Contribution to journal › Article
-
Mark
High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden
(
- Contribution to journal › Article
-
Mark
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
(
- Contribution to journal › Article
- 2022
-
Mark
Surveillance of COVID-19 vaccine effectiveness : A real-time case-control study in southern Sweden
(
- Contribution to journal › Article
-
Mark
High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population–first results from a cohort study in Southern Sweden
(
- Contribution to journal › Article
- 2021
-
Mark
Axillary lymphadenopathy at the time of COVID-19 vaccination : ten recommendations from the European Society of Breast Imaging (EUSOBI)
(
- Contribution to journal › Article